Moneytree: No problem. I think you are right about expecting revenue this quarter. I don't know where it would come from? It is possible Gerald may do some deal that brings in up front money....but I'm not considering that as "revenue."
I think having these 3 sources of Diagnostic revenue ramping up by summer and becoming significant by Fall should have an impact on the stock price....at some point.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links